Cargando…

Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis

BACKGROUND: Anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is a systemic autoimmune disease characterized by destructive vascular inflammation. Two prominent ANCA autoantigens are myeloperoxidase (MPO) and proteinase 3 (PR3), and transcription of MPO and PRTN3, the genes...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jiajin, Ge, Heng, Poulton, Caroline J., Hogan, Susan L., Hu, Yichun, Jones, Britta E., Henderson, Candace D., McInnis, Elizabeth A., Pendergraft, William F., Jennette, J. Charles, Falk, Ronald J., Ciavatta, Dominic J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057507/
https://www.ncbi.nlm.nih.gov/pubmed/27752292
http://dx.doi.org/10.1186/s13148-016-0251-0
_version_ 1782459084565381120
author Yang, Jiajin
Ge, Heng
Poulton, Caroline J.
Hogan, Susan L.
Hu, Yichun
Jones, Britta E.
Henderson, Candace D.
McInnis, Elizabeth A.
Pendergraft, William F.
Jennette, J. Charles
Falk, Ronald J.
Ciavatta, Dominic J.
author_facet Yang, Jiajin
Ge, Heng
Poulton, Caroline J.
Hogan, Susan L.
Hu, Yichun
Jones, Britta E.
Henderson, Candace D.
McInnis, Elizabeth A.
Pendergraft, William F.
Jennette, J. Charles
Falk, Ronald J.
Ciavatta, Dominic J.
author_sort Yang, Jiajin
collection PubMed
description BACKGROUND: Anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is a systemic autoimmune disease characterized by destructive vascular inflammation. Two prominent ANCA autoantigens are myeloperoxidase (MPO) and proteinase 3 (PR3), and transcription of MPO and PRTN3, the genes encoding the autoantigens, is associated with disease activity. We investigated whether patients with AAV have alterations in histone modifications, particularly those associated with transcriptional activation, at MPO and PRTN3. RESULTS: We identified a network of genes regulating histone modifications that were differentially expressed in AAV patients compared to healthy controls. We focused on four genes (EHMT1 and EHMT2, ING4, and MSL1) and found their expression correlated with expression of MPO and PRTN3. Methylation of histone H3K9, catalyzed by EHMT1 and EHMT2 and associated with gene silencing, was most depleted at MPO and PRTN3 in patients with active disease and the highest MPO and PRTN3 expression. Acetylation of histone H4K16, modified by complexes containing ING4 and MSL1 and associated with gene activation, was most enriched at MPO and PRTN3 in patients with active disease and the highest MPO and PRTN3 expression. Methylation at H3K4, a mark of transcriptional activation, was enriched at MPO and PRTN3 in patients and healthy controls. CONCLUSIONS: MPO and PRTN3 in neutrophils of AAV patients with active disease have a distinct pattern of histone modifications, which implicates epigenetic mechanisms in regulating expression of autoantigen genes and suggests that the epigenome may be involved in AAV pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-016-0251-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5057507
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50575072016-10-17 Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis Yang, Jiajin Ge, Heng Poulton, Caroline J. Hogan, Susan L. Hu, Yichun Jones, Britta E. Henderson, Candace D. McInnis, Elizabeth A. Pendergraft, William F. Jennette, J. Charles Falk, Ronald J. Ciavatta, Dominic J. Clin Epigenetics Research BACKGROUND: Anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is a systemic autoimmune disease characterized by destructive vascular inflammation. Two prominent ANCA autoantigens are myeloperoxidase (MPO) and proteinase 3 (PR3), and transcription of MPO and PRTN3, the genes encoding the autoantigens, is associated with disease activity. We investigated whether patients with AAV have alterations in histone modifications, particularly those associated with transcriptional activation, at MPO and PRTN3. RESULTS: We identified a network of genes regulating histone modifications that were differentially expressed in AAV patients compared to healthy controls. We focused on four genes (EHMT1 and EHMT2, ING4, and MSL1) and found their expression correlated with expression of MPO and PRTN3. Methylation of histone H3K9, catalyzed by EHMT1 and EHMT2 and associated with gene silencing, was most depleted at MPO and PRTN3 in patients with active disease and the highest MPO and PRTN3 expression. Acetylation of histone H4K16, modified by complexes containing ING4 and MSL1 and associated with gene activation, was most enriched at MPO and PRTN3 in patients with active disease and the highest MPO and PRTN3 expression. Methylation at H3K4, a mark of transcriptional activation, was enriched at MPO and PRTN3 in patients and healthy controls. CONCLUSIONS: MPO and PRTN3 in neutrophils of AAV patients with active disease have a distinct pattern of histone modifications, which implicates epigenetic mechanisms in regulating expression of autoantigen genes and suggests that the epigenome may be involved in AAV pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-016-0251-0) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-12 /pmc/articles/PMC5057507/ /pubmed/27752292 http://dx.doi.org/10.1186/s13148-016-0251-0 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Yang, Jiajin
Ge, Heng
Poulton, Caroline J.
Hogan, Susan L.
Hu, Yichun
Jones, Britta E.
Henderson, Candace D.
McInnis, Elizabeth A.
Pendergraft, William F.
Jennette, J. Charles
Falk, Ronald J.
Ciavatta, Dominic J.
Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis
title Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis
title_full Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis
title_fullStr Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis
title_full_unstemmed Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis
title_short Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis
title_sort histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057507/
https://www.ncbi.nlm.nih.gov/pubmed/27752292
http://dx.doi.org/10.1186/s13148-016-0251-0
work_keys_str_mv AT yangjiajin histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis
AT geheng histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis
AT poultoncarolinej histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis
AT hogansusanl histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis
AT huyichun histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis
AT jonesbrittae histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis
AT hendersoncandaced histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis
AT mcinniselizabetha histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis
AT pendergraftwilliamf histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis
AT jennettejcharles histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis
AT falkronaldj histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis
AT ciavattadominicj histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis